The US Preventive Services Task Force (USPSTF), convened by the Agency for Healthcare Research and Quality, draws from a panel of national experts to provide evidence-based recommendations regarding various clinical preventive services that include screenings as well as preventive medications and behavioral counseling. These recommendations focus on assessing a balance of benefits and harms, while excluding issues of cost from their analysis of the preventive service in view. In 2016, the USPSTF released recommendations regarding colorectal cancer (CRC) screening1; such recommendations are particularly important given that CRC is currently the third leading cause of cancer death in the world and the second leading cause of cancer death in the United States.2 As screening for CRC has been estimated to reduce the incidence and mortality from this disease,3 screening adherence and barriers to screening are matters of gravity.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Stewart DB. Updated USPSTF Guidelines for Colorectal Cancer Screening: The Earlier the Better. JAMA Surg. Published online May 18, 2021. doi:10.1001/jamasurg.2021.1939
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: